GTP
RDY icon

Global Thematic Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

Global Thematic Partners’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,883,750
Closed -$19.3M – 75
2016
Q2 		$19.3M Buy
1,883,750
+446,690
+31% +$4.09M 0.48% 56
2016
Q1 		$13M Buy
1,437,060
+1,203,930
+516% +$10.8M 0.28% 68
2015
Q4 		$2.16M Buy
+233,130
New +$2.55M 0.04% 78

Other funds holding RDY

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Global Thematic Partners's RDY Position: Q3 2016 in Review

Global Thematic Partners sold out of Dr. Reddy's Laboratories (RDY) in Q3 2016, closing a stake of 1,883,750 shares — an estimated $19.3M sold.

Global Thematic Partners first reported a position in RDY in Q4 2015 and held it in 3 quarters. The position peaked at $19.3M in Q2 2016. 157 funds tracked by Wall St. Rank hold RDY as of Q3 2016.

  • Global Thematic Partners reported no remaining Dr. Reddy's Laboratories position as of Q3 2016 after selling out during the quarter.
  • Global Thematic Partners sold 1,883,750 Dr. Reddy's Laboratories shares in Q3 2016, an estimated $19.3M.
  • Global Thematic Partners first reported a position in Dr. Reddy's Laboratories in Q4 2015 and held it in 3 quarters.
  • Global Thematic Partners's Dr. Reddy's Laboratories position peaked at $19.3M in Q2 2016.
  • 157 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2016.

Based on Global Thematic Partners's 13F filing for Q3 2016, filed 7 Nov 2016.